Program

 

Sunday 15 October 2017

8:30 Workshop Opening
Rob Aarnoutse, PharmD, PhD
 
  Session 1: Pharmacokinetics & pharmacodynamics of new & redeveloped TB drugs
  Chairs:
8:45 New drugs: Betalactam
David Barros, PhD - GlaxoSmithKline, Spain
9:15Oral Abstract Presentations
10:15Discussion
 
10:30Coffee Break + Guided Poster Session
 
  Session 2: Pharmacokinetics & pharmacodynamics of existing TB drugs
  Chairs:
11:00 QTc prolongation in TB regimens (safety)
11:30Oral Abstract Presentations
12:30Discussion
 
12:45Lunch
 
  Guided Poster Session
  Chairs:
13:30 Guided Poster Session
 
  Session 3: Population pharmacokinetics and pharmacokinetic-pharmacodynamic modelling
  Chairs:
14:00 Benefits of data collaboration – personalized tailoring regimens
Rada Savic, PharmD, PhD - University of California, San Francisco, USA
14:30 Oral Abstract Presentations
15:30 Discussion
 
15:45Coffee Break + Guided Poster Session
 
  Session 4: Drug development and optimization: approaches and tools
  Chairs:
16:15 Translate pre-clinical models to clinical outcomes
Tawanda Gumbo, MD - Southwestern Medical Center, USA
16:45 Oral Abstract Presentations
17:45Discussion
 
18:00Closure of the Workshop - Workshop Dinner

The following invited speakers have confirmed their contribution to the workshop: